Key result
Patients with atrial fibrillation were significantly more likely than clinicians to rank the ability to reduce DOAC dose if needed as very important (70.5% vs 43.6%; P<0.001).
Why the study?
DOAC underdosing is frequent in nonvalvular AF, but little is known about clinician knowledge and patient or clinician preferences regarding DOAC dosing.
What are the differences in preferences and knowledge gaps regarding DOAC dosing between clinicians and patients with atrial fibrillation?
Cross-Sectional (n=583)
What are the differences in preferences and knowledge gaps regarding DOAC dosing between clinicians and patients with atrial fibrillation?
Absolute Event Rate: 70.5% vs 43.6%
p-value: p=<0.001
There are significant knowledge gaps among clinicians regarding DOAC dosing and differing preferences between patients and clinicians, particularly regarding the importance of dose reduction.
No takes yet. Share an insight, caveat, or question.
Clinicians may underestimate patient preference for DOAC dose flexibility; hypothesis-generating for shared decision-making research in AF.
Rymer et al. (2021) conducted a cross-sectional in Atrial fibrillation (n=583). Patient perspective vs. Clinician perspective was evaluated on Ranking the ability to reduce anticoagulation dose if needed as very important (p=<0.001). Patients with atrial fibrillation were significantly more likely than clinicians to rank the ability to reduce DOAC dose if needed as very important (70.5% vs 43.6%; P<0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: